Premium
Impact of Buccotherm® on xerostomia: a single blind study
Author(s) -
Alpöz Esin,
Çankaya Hülya,
Güneri Pelin,
Epstein Joel B.,
Boyacioglu Hayal,
Kabasakal Yasemin,
Ocakci Pınar Talu
Publication year - 2014
Publication title -
special care in dentistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.328
H-Index - 41
eISSN - 1754-4505
pISSN - 0275-1879
DOI - 10.1111/scd.12074
Subject(s) - medicine , dry mouth , placebo , swallowing , dentistry , visual analogue scale , mastication , saliva , clinical trial , physical therapy , alternative medicine , pathology
Objective The purpose of this single blind study was to investigate effects of Buccotherm® spray on subjective symptoms of xerostomia patients. Methods Twenty patients with dry mouth complaint were instructed to use placebo six times a day for 2 weeks. After a wash period, mineral water spray was provided. Patients were asked to reply questions regarding dry mouth using visual analog scale (VAS). Baseline and subsequent subjective findings on 1 hour after the application of the materials at the end of 1st, 7th, and 14th days were recorded. Results At the end of 14‐day treatment, no statistically significant differences were observed between the efficacy of placebo and commercial mineral water dental spray ( p > 0.05). The VAS scores revealed that difficulty in mastication ( p = 0.006), difficulty in swallowing ( p = 0.00), need to sip liquids while eating ( p = 0.000), difficulty in speech ( p = 0.003), and waking up at night to sip water ( p = 0.005) were statistically lower for placebo than commercial mineral water spray. Conclusion The commercial mineral water dental spray was not more efficient than placebo in the management of dry mouth‐related symptoms. Clinical relevance This study emphasizes the fundamental role of saliva in oral health and evaluates the clinical utility of a commercial dental spray.